GPCRs after 17 Flashcards
3 methods of down regulation
Nucleotide exchange
Desensitisation- PKA/PKC or GrkS
Subunit swapping
Desensitisation of BAR
PKA acts on c3 and tail
7 BARK sites on tail (Ser/thr)
Reversed by phosphodiesterase
Heterologous desensitisation
GPCR -> PKA
Non specific of whether receptor is activated
Activation of one can desensitise another
Homologous desensitisation
GRK-1- rhodopsin kinase
GRK-2- BARK
GRK2 Recruited by surplus GBY subunits (isoprenylated) GRK-2 has a PH domain that binds BY B-arrest in docks Endocytosis
Functions of BY
5
Inactive complex Anchoring via isoprenylation MACH -> BY acts on K+ Regulates AC 2,4 Regulation of BARK
b arrest in complex
Clathrin and AP2 -> endocytosis
AJK-1, MKKY, JNK-1 -> c-Jun cascade
B arrestin scaffold and dynamin
Interaction of B arrestin with c-src
Causes internalisation as promotes Yp of dynamin
C-src and dynamin mutants may inhibit clathrin dependent internalisation
Clinical application of receptor internalisation
CCR5 to prevent R5 HIV-1 entry Glycoprotein 120 can't bind CCR5 Uses agonists or antagonists Only affects CCR5 not CXC4 Without inducing chemotaxis in vitro Agonist ESN-196
3 pathways of GRK2/BARK activity
Recruits PKA, PKC, SRC, ERK AND CAM
Sequesters Gaq to prevent coupling to PLC
B arrestin recruitment. Allows PDE4 to membrane, degrades high camp levels
Two different PDEs recruited by B1 and B1 ARs in myocytes
B1- preformed with PDE48. PKA causes PDE dissociation
B2- recruitment of arrestin, which then recruits PDE4D5
Means that the different splice variants of PDE can cause contraction (B1) or inhibition (B2)
AKAP
Camp dependent protein kinase anchoring protein
Can localise PKA, PDE etc.
Camp pathway for lung disease treatment
B2 agonist (albuterol) AC agonist, forskolin M2 antagonists (ipratropiumbromide) PDE inhibitors, specific for Pde4 All act to increase camp MLCK-Pi to increase bronchodilation Phosphorylates K channel to stop leaving
Role of mAKAP in heart muscle
AKAP15
Anchors PKA and PDE
To nuclear membrane
Local regulation of camp levels
PKA can act on PDE which activates and lowers camp
AKAP15- cytosolic side near Ca channel.
PKA activates Ca
The AKAP15 localises PKA to the Ca channels
AKAP complexes
B2AR AC PKA EPAC (acts as a GEF for rap1) PDE
Rhodopsin basic
Opsin (GPCR) linked to 11-cis-retinal
Transduction is the G protein
PTX (R174) and CTX (C347) sensitive
Rhodopsin and light transaction
Light causes photo isomerisation of 11-cis retinal -> all trans retinal
Forms unstable meta-rhodopsin II
This activates Gt
Gt acts to removes inhibitory Y of cGMP PDE
cGMP -> GMP
cGMP gated NA/ca close
Hyperpolarisation stops neurotransmitter -> relay to brain
Gt/PDE complex recruits RGS9-GB5
GTPase activity
PDE inactivated
Switching off the rhodopsin cascade
Low Ca activates guanylyl cyclase
Increased cGMP re opens gate
Ca entry and end to hyperpolarisation
Also GAP
Inhibition of the cascade by GRK1
Only light activated rhodopsin
Binds to C3 loop
Arrestin binds to phosphorylated opsin C-terminus
Always membrane associated
Recoverin- inhibits rhodopsin at high Ca (no light)
This stops GRK from being always active, so only really active st very low Ca/very bright light
Activation of gene expression by GOCRs
Increased camp
PKA catalytic units trans located to nucleus
Phosphorylate S133 of CREB
CREB binds to CRE
Associates with co factor CBP/P300 which is a histone acetylase
Transcription
PI -> DAG and ip3
PI -> PIP with PI-4 kinase
PIP -> PIP2 with PIP-5 kinase
PLC (cuts phosphoester bond)
G protein can act on PLC- Gq, Gao and Gat
Gives PKC activation
Why is Gq PTX resistant?
Lacks a Cys in the c terminal hexapeptide stretch
No ribosylstion target
Receptors coupled to PIP2 hydrolysis
Muscarinic H1 P2 A1 Thrombin Vasopressin Serotonin (only 5HT2)
Serotonin receptor subtypes
Types 1-7
1- Gi camp 2- Gq -> IP3 DAG 4- Gs camp 5- Gi 6+ 7 Gs
Isoforms of PLC
Beta- activation by GPCR, Gaq and Gao
Gamma- activation by RTK, activated by phosphorylation
Bifurcating PI pathway
Write it out
Domain structure of PKC
How is it activated
Phorbal esters
Pseudo phosphorylation site near the N terminus
Inert alanine instead of Ser/thr
Binding of ca, DAG and phosphatidylserine activate (localises to membrane)
Binds to DAG and phorbal esters through zinc fingers
TPA (tetra phorbal acetate) and PMA (phorbal myristate acetate)
Act as DAG analogues
PKA and PKC comparison
BAR -> PKA -> TRE by Jun and Fos
A1AR -> PKC -> CRE by CREB
Fates of DAG
DAG lipase creates AA
Cyclooxygenase converts this to Prostaglandins and Thromboxanes
Fate of IP3
Release of Ca from ER
Back to inositol
Or used to create Ip4, ip5 or ip6